[Summary] Cell immunotherapy
JW Therapeutics (HKEx: 2126) is an independent, innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherapy products. JW Therapeutics has built a technology and product development platform for cell immunotherapy, as well as a promising product pipeline covering hematologic malignancies and solid tumors, aiming to bring the hope of a cure to patients in China and globally, and to promote the healthy and standardized development of China's cell immunotherapy industry.
JW Therapeutics (HKEx: 2126) is an independent, innovative biotechnology company focusing on developing, manufacturing commercializing cell immunotherapy products. Founded in 2016, JW Therapeutics is committed to becoming an innovation leader in cell immunotherapy. The company has built a world- platform ftechnology product development in cell immunotherapy, as well as a promising product pipeline covering both hematologic mancies solid tumors, to bring the hope of a cure fChinese global patients, to lead the healthy standardized development of China’s cell immunotherapy industry.
What does Shanghai JW Therapeutics Biotechnology Co., Ltd. require? Who is JW Therapeutics hiring? JW Therapeutics recruitment: 销售类占比最多占58.2%,其次是经营管理类占37.3%. What education can get in at JW Therapeutics? 本科占比最多占73.1%,其次是硕士占14.9%. High education required at JW Therapeutics? 硕士占14.9%. Work experience required at JW Therapeutics? 1-3年占比最多占50.7%,其次是5-10年占17.9%. Where are the job locations at JW Therapeutics? 上海占比最多占40.3%,其次是苏州占14.9%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows